参附注射液治疗心脏骤停后脑复苏的研究进展  

Research on the treatment of cerebral resuscitation after cardiac arrest with Shenfu Injection

作　　者：陈兴华[1] CHEN Xinghua(Department of Emergency,Xianhu Campus of the First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine,Nanning,Guangxi 530022,China)

机构地区：[1]广西中医药大学第一附属医院仙葫院区急诊科,广西南宁530022

出　　处：《医药前沿》2024年第18期30-32,共3页Journal of Frontiers of Medicine

摘　　要：心脏骤停是由多种因素引起的心脏停止泵血,导致患者出现意识丧失、循环衰竭、呼吸心跳停止的临床急危症,具有极高的病死率。脑复苏的程度是判断心肺复苏术成功的关键环节之一,对于评估患者的预后具有重要的价值。参附注射液是治疗心脏骤停后脑复苏的有效方法之一,已在临床急救中广泛应用。本文通过分析心脏骤停后脑复苏的发病机制,总结多靶点之参附注射液在临床及实验方面的研究,以期为机制学研究提供新思路。Cardiac arrest is a clinical emergency caused by various factors that stop pumping blood to the heart,leading to loss of consciousness,circulatory failure,and respiratory and cardiac arrest in patients.It has a high mortality rate,and reducing the degree of cerebral resuscitation is one of the key factors in determining the success of cardiopulmonary resuscitation surgery,which is of great value for evaluating the prognosis of patients.Shenfu Injection is one of the effective methods for treating cerebral resuscitation after cardiac arrest,which is widely used in clinical emergency treatment.This article aims to analyze the pathogenesis of cerebral resuscitation after cardiac arrest,summarize the clinical and experimental research of multi-target Shenfu Injection,and provide new ideas for mechanistic research.

关 键 词：综述 参附注射液 治疗 心脏骤停 脑复苏 

分 类 号：R742[医药卫生—神经病学与精神病学]